Validity of Serum Cystatin C for Prediecting Obesity Nephropathy |
Asefy, Zahra
(Department of Clinical Biochemistry, Tarbiat Modares University)
Amirrasouli, Hooshang (Department of Laboratory Medicine, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences) Khoyi, Masood (Department of Clinical Biochemistry, Tarbiat Modares University) Hashemi, Vida (Department of Clinical Biochemistry, Tarbiat Modares University) |
1 | Hu, G., Qiao, Q., Tuomilehto, J., Balkau, B., Borch-Johnsen, K., and Pyorala, K. (2004). Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164, 1066-1076. DOI |
2 | Azizi, F., Salehi, P., Etemadi, A., and Zahedi-Asl, S. (2003). Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 61, 29-37. DOI |
3 | Onat, A., Ceyhan, K., Basar, O., Erer, B., Toprak, S., and Sansoy, V. (2002). Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 165, 285-292. DOI ScienceOn |
4 | Gupta, A., Gupta, R., Sarna, M., Rastogi, S., Gupta, V.P., and Kothari, K. (2003). Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract 61, 69-76. DOI ScienceOn |
5 | Wisse, B.E. (2004). The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15, 2792-2800. DOI ScienceOn |
6 | Iseki, K., Ikemiya, Y., Kinjo, K., Inoue, T., Iseki, C., Takishita, S. (2004): Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65: 1870-1876. DOI ScienceOn |
7 | Ejerblad, E., Fored, M., Lindblad, P., Fryzek, J., McLaughlin, J.K., and Nyren, O. (2006). Obesity and risk of chronic renal failure. J Am Soc Nephrol 17, 1695-1702. DOI |
8 | Filler, G., Boken Kamp, A., Hotmann, W., Le Bricon, T., Martnez-Bru, C., and Grubb, A. (2005). Cystatin C as marker of GFR, history indication and future research. Clin Biochem 38, 1-8. DOI |
9 | Henskens, Y.M.C., Veerman, E.C.I., and Nieuw Amerongen, A.V. (1996). Cystatins in health and disease. Biol Chem Hoppe-Seyler 377, 71-86. |
10 | Sarnak, M.J., Katz, R., Stehman-Breen, C.O., Fried, L.F., Nancy Swords Jenny, Bruce, M.P., Newman, A., Siscovick, D., Shlipak, M; The Cardiovascular Health Study. (2005). Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults. Ann Intern Med 142, 497-505. DOI |
11 | O'Hare, A., Newman, A., Katz, R., Fried, L., Stehman-Breen, C., Seliger, S., Siscovick, D., Shlipak, M.S., and Cystatin, C. (2005). Incident peripheral arterial disease events in the elderly. Arch Intern Med 165, 2666- 2670. DOI |
12 | Hoehner, C.M., Greenlund, K.J., Rith-Najarian, S., Casper, M.L., and McClellan, W.M. (2002). Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter- Tribal Heart Project. J Am Soc Nephrol 13, 1626-1634. DOI ScienceOn |
13 | Hsu, C.Y., McCulloch, C.E., Iribarren, C., Darbinian, J., and Go, A.S. (2006). Body mass index and risk for end-stage renal disease. Ann Intern Med 144, 21-28. DOI |
14 | Armstrong, K.A, Campbell, S.B, Hawley, C.M., Nicol, D.L, Johson, D.W., and Isbel, N.M. (2005). Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients. Am J Transplant 5, 2710-2718. DOI |
15 | Agnani, S., Vachharajani, V.T, Gupta, R., Atray, N.K., and Vachharajani, T.J. (2005). Does treating obesity stabilize chronic kidney disease? BMC Nephrol 6, 7. DOI |
16 | Chagnac, A., Weinstein, T., Herman, M., Hirsh, J., Gafter, U., and Ori, Y. (2003). The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14, 1480-1486. DOI ScienceOn |
17 | Kambham, N., Markowitz, G.S., Valeri, A.M., Lin, J., and D'Agati, V.D. (2001). Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59, 1498-1509. DOI ScienceOn |
18 | Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. (1993). Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259, 87-91. DOI ScienceOn |
19 | Wisse. B.E. (2004). The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15, 2792-2800 DOI ScienceOn |
20 | Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., and Garg, R. (2005). Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111, 1448-1454. DOI ScienceOn |